We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00335348
First Posted: June 9, 2006
Last Update Posted: January 9, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
Peter MacCallum Cancer Centre, Australia
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):